GENERALIZED ANXIETY DISORDER
Clinical trials for GENERALIZED ANXIETY DISORDER explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED ANXIETY DISORDER trials appear
Sign up with your email to follow new studies for GENERALIZED ANXIETY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New anxiety drug shows promise in early trial
Symptom relief Not yet recruitingThis study tests a single dose of an experimental drug called SYT-510 in 24 adults with generalized anxiety disorder. The goal is to see if it reduces anxiety and changes brain activity related to fear. Participants will receive either the drug or a placebo and be monitored for s…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE2 • Sponsor: Synendos Therapeutics AG • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC
-
New anxiety shot shows promise in early trial
Symptom relief Not yet recruitingThis study tests whether a single dose of RE104 injection can reduce anxiety symptoms in people with Generalized Anxiety Disorder (GAD). 64 adults with GAD will receive either RE104 or a placebo, and their anxiety levels will be measured after 4 weeks. The goal is to see if RE104…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated May 01, 2026 15:56 UTC
-
Brain zaps for anxiety? new study tests targeted stimulation
Symptom relief Not yet recruitingThis study tests a non-invasive brain stimulation method called cTBS for people with generalized anxiety disorder. 60 adults will receive either real or placebo stimulation to two brain areas daily for a week. Researchers will measure anxiety changes and brain activity using MRI …
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
Liver function may change how anxiety drug works in body
Knowledge-focused Not yet recruitingThis early-stage study looks at how the body processes buagafuran, an experimental anxiety drug, in people with liver impairment compared to those with normal liver function. About 24 adults will take a single dose and have their blood levels and safety monitored. The goal is to …
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE1 • Sponsor: Beijing Union Pharmaceutical Factory Ltd • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC
-
Anxiety patients share their therapy experiences in new study
Knowledge-focused Not yet recruitingThis study interviews 30 adults with generalized anxiety, social anxiety, or PTSD who have already completed a larger trial comparing two therapies: metacognitive therapy (MCT) and cognitive-behavioral therapy (CBT). The goal is to understand what participants thought about each …
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:04 UTC